Inventor
Mark Allen Abrams
Inventor
St. Louis, MO, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides26%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests10%
C12NMicroorganisms or enzymes7%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
C07CAcyclic or carbocyclic compounds4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
C01PIndexing scheme relating to structural and physical aspects of solid inorganic compounds1%
PatentTitleYear
11,103,859UZM-54 and transalkylation process using same202111,084,766Toluene disproportionation using an enhanced UZM-39 aluminosilicate zeolite202111,084,767Toluene disproportionation using an enhanced UZM-44 aluminosilicate zeolite202110,994,266Process for making modified small-crystal mordenite, transalkylation process using same, and modified small-crystal mordenite20217,091,319'IL-3 variant hematopoiesis fusion protein'20066,479,261'Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells'20026,458,931'Interleukin-3 (IL-3) multiple mutation polypeptides'20026,440,407'Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides'20026,436,387'Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins'20026,413,509'Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors'20026,403,076'Compositions for increasing hematopoiesis with interleukin-3 mutants'20026,379,662'Co-administration of interleukin-3 mutant polypeptides with CSF\'s for multi-lineage hematopoietic cell production'20026,361,977'Methods of using multivariant IL-3 hematopoiesis fusion protein'20026,361,976'Co-administration of interleukin-3 mutant polypeptides with CSF\'S for multi-lineage hematopoietic cell production'20026,153,183'Co-administration of interleukin-3 mutant polypeptides with CSF\'s or cytokines for multi-lineage hematopoietic cell production'20006,132,991'Human interleukin-3 (IL-3) variant fusion proteins'20006,093,395'Co-administration of interleukin-3 mutant polypeptides with CSF\'s for multi-lineage hematopoietic cell production'20006,074,639'Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins'20006,060,047'Co-administration of interleukin-3 mutant polypeptides with CSF\'s for multi-lineage hematopoietic cell production'20006,057,133'Multivariant human IL-3 fusion proteins and their recombinant production'20006,051,217'Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides'20006,030,812'Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors'20006,022,535'Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors'20005,997,857'Co-administration of interleukin-3 mutants with colony stimulating factors'19995,997,860'Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines'19995,858,347'Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors'19995,772,992'Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors'19985,738,849'Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them'19985,677,149'Interleukin-3 (IL-3) mutant polypeptides and their recombinant production'19975,604,116'Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2002Patents assigned to SEARLE & CO (18)· patent assignee history
1997–2006Based in St. Louis, MO, US· patent location history
2006Patents assigned to ABRAMS MARK ALLEN (1)· patent assignee history
2006Patents assigned to BAUER S CHRISTOPHER (1)· patent assignee history
2006Patents assigned to BRAFORD-GOLDBERG SARAH RUTH (1)· patent assignee history
2021Patents assigned to UOP LLC (4)· patent assignee history
2021Based in Chicago, IL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SEARLE & CO | 18 | 1997–2002 |
| UOP LLC | 4 | 2021 |
| ABRAMS MARK ALLENself | 1 | 2006 |
| BAUER S CHRISTOPHER | 1 | 2006 |
| BRAFORD-GOLDBERG SARAH RUTH | 1 | 2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| St. Louis, MO, US | 26 | 1997–2006 |
| Chicago, Illinois, US | 4 | 2021 |